Robert Bradway has been named executive vice president and chief financial officer, Amgen. He will be responsible for the company’s finance, strategy and investor relations operations. Mr. Bradway replaces Richard Nanula, who is leaving the company to pursue other opportunities. Mr. Bradway joined the company in 2006 as vice president, operations strategy. Prior to that, he spent 18 years at Morgan Stanley in New York and London, where he was a managing director in investment banking. ...